152 related articles for article (PubMed ID: 32937740)
1. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia.
Zarobkiewicz M; Kowalska W; Chocholska S; Tomczak W; Szymańska A; Morawska I; Wojciechowska A; Bojarska-Junak A
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937740
[TBL] [Abstract][Full Text] [Related]
2. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
3. [Immune function of myeloid-derived suppressor cells and its mechanism in obstructive sleep apnea syndrome].
Chen SW; Li J; Xiang B; Xu SJ; Wang L
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):295-300. PubMed ID: 32075359
[No Abstract] [Full Text] [Related]
4. Expression of Inhibitory Molecules (Arginase-1, IDO, and PD-L1) by Myeloid-Derived Suppressor Cells in Multiple Myeloma Patients in Remission.
Tyrinova TV; Batorov EV; Aristova TA; Ushakova GY; Sizikova SA; Denisova VV; Ostanin AA; Chernykh ER
Bull Exp Biol Med; 2022 Nov; 174(1):71-75. PubMed ID: 36437327
[TBL] [Abstract][Full Text] [Related]
5. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
Jitschin R; Braun M; Büttner M; Dettmer-Wilde K; Bricks J; Berger J; Eckart MJ; Krause SW; Oefner PJ; Le Blanc K; Mackensen A; Mougiakakos D
Blood; 2014 Jul; 124(5):750-60. PubMed ID: 24850760
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
7. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
8. CD14
Liu J; Zhou Y; Huang Q; Qiu L
Oncol Lett; 2015 Mar; 9(3):1167-1172. PubMed ID: 25663875
[TBL] [Abstract][Full Text] [Related]
9. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Fetoprotein as a Factor of Differentiation and Functional Activity of Myeloid-Derived Suppressor Cells.
Shardina KY; Zamorina SA; Timganova VP; Bochkova MS; Uzhviyuk SV; Chereshnev VA
Bull Exp Biol Med; 2023 Aug; 175(4):535-543. PubMed ID: 37773570
[TBL] [Abstract][Full Text] [Related]
11. Ascites-derived IL-6 and IL-10 synergistically expand CD14
Wu L; Deng Z; Peng Y; Han L; Liu J; Wang L; Li B; Zhao J; Jiao S; Wei H
Oncotarget; 2017 Sep; 8(44):76843-76856. PubMed ID: 29100353
[TBL] [Abstract][Full Text] [Related]
12. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
13. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
15. [Effect of concurrent chemoradiotherapy and radiotherapy alone on peripheral myeloid-derived suppressor and T regulatory cells in patients with nasopharyngeal cancer].
Dai XC; Liu LQ; Wang BH; Wang CM; Ma L; Cao WM; Dai EX
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):579-583. PubMed ID: 28835079
[No Abstract] [Full Text] [Related]
16. Presence of Infected Gr-1
Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
Front Immunol; 2018; 9():2317. PubMed ID: 30386330
[TBL] [Abstract][Full Text] [Related]
17. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients.
Woś J; Chocholska S; Kowalska W; Tomczak W; Szymańska A; Karczmarczyk A; Szuster-Ciesielska A; Wojciechowska A; Bojarska-Junak A
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198760
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival.
Fallah J; Diaz-Montero CM; Rayman P; Wei W; Finke JH; Kim JS; Pavicic PG; Lamenza M; Dann P; Company D; Stephenson A; Campbell S; Haber G; Lee B; Mian O; Gilligan T; Garcia JA; Rini B; Ornstein MC; Grivas P
Clin Genitourin Cancer; 2020 Dec; 18(6):500-508. PubMed ID: 32340875
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]